As of November 14, 2026, Evolus, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 13, 2026 (Form 8-K, March 13, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Evolus, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Evolus, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-13. Every row below is cited to the filing it comes from, and this page adds each new change as Evolus, Inc. files it.
Also on the record for Evolus, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 9, 2026 | Stake report, Schedule 13G/A, by Soleus Capital Master Fund, L.P. | 7.7% of the class | 5%+ stakes | Source |
| August 31, 2026 | Stake report, Schedule 13G, by Soleus Capital Master Fund, L.P. | 5.3% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Caligan Partners LP | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC | 1.92% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Timothy P. Lynch | 9.9% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Caligan Partners LP | 6.4% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Nantahala Capital Management, LLC | 8.85% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Timothy P. Lynch | 7.9% of the class | 5%+ stakes | Source |
| August 18, 2025 | Stake report, Schedule 13G, by Timothy P. Lynch | 6.3% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G, by Caligan Partners LP | 5.2% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Perceptive Advisors LLC | 3.8% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Evolus, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Evolus, Inc. and the records around it.
Evolus, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Timothy P. Lynch also filed stake reports on 1 other company: AEON Biopharma, Inc. (Aug 2026)
- Caligan Partners LP also filed stake reports on 9 other companies: Avalo Therapeutics, Inc. (Aug 2026), Cellectar Biosciences, Inc. (Aug 2026), Faeth Therapeutics, Inc. (Aug 2026)
- Soleus Capital Master Fund, L.P. also filed stake reports on 24 other companies: Beta Bionics, Inc. (Nov 2026), INSPIRE MEDICAL SYSTEMS, INC. (Nov 2026), NOVOCURE LIMITED (Nov 2026)
Watch Evolus, Inc.
Get an email when Evolus, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Evolus, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Evolus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Evolus, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-13 | Reported | not named in the filing | 8-K, 2026-03-13 |
New leaders reset buying decisions — get the Full Report on Evolus, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Evolus, Inc., with the record behind each one.
Find candidates like senior executive at Evolus, Inc.Every change, in the filing's words
Reported
Her departure resulted in an imbalance among the classes of directors under the Company's classified board structure.
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
- Director Reclassification As previously disclosed, Simone Blank stepped down from the board of directors (the "Board") of Evolus, Inc. (the "Company") to support the Company's board refreshment efforts.
- On March 13, 2026, in order to restore balance among the classes of directors, the Board approved actions to reclassify Vikram Malik from Class III to Class II.
- In order to effect this reclassification, Mr. Malik resigned as a Class III director effective immediately prior to his appointment to the Board.
- The Board accepted the resignation and immediately thereafter appointed Mr. Malik to the Board and designated him as a Class II director.
- Mr. Malik will serve as a Class II director until the Company's 2026 annual meeting of stockholders, at which time the Class II directors are scheduled to stand for election.
- Mr. Malik's service on the Board was continuous and uninterrupted by the foregoing actions.
- Mr. Malik will continue to serve as Chairman of the Board and as a member of the Compensation Committee of the Board.
- Mr. Malik did not receive any new equity award in connection with his appointment as a Class II director, and his existing equity awards will continue to vest in accordance with their original terms.
Tools for this story
Each opens in a new tab, filled in for Evolus, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
